fda update tirzepatide confirms shortage is still over, gives compounders a grace period FDA Says Shortage of GLP-1

Inactivation of muscle insulin and IGF-I receptors and insulin responsiveness

It is an unapproved investigational compound that did not complete clinical development, has not been authorized by Health Canada for any human or veterinary indication, and is not intended to diagnose, treat, cure, or prevent any disease

Blood Sugar Swings and ADHD Symptom Flares Unstable blood sugar may worsen: Focus Mood Irritability Impulse control But heres the thing

This doesn't create a dangerous drug interaction, but it does mean your body is working harder to process both substances simultaneously

The diagnostic approach is identical: serial testing over 12 weeks or a 4-week washout period before definitive evaluation